If 1801 fails then this becomes a shell and should trade around cash backing, dependent upon them getting rid of all the ridiculous salaries they're paying. Hopefully they'll still have a good pile of cash left to pick up a new project and fund the initial stages.
I do have a bit of hope for 1801 though, need to spend some more time closer to the trial results to really look through the details but the recent announcement looked good on first read - just worried about the fine print i might have missed
Botanix Pharmaceuticals Downgraded to Hold from Buy by Bell Potter, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 35.0¢ | $1.693M | 4.721M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40362 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 50704 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |